Coregistration-Fusion MRI Identifies Missed MS Disease Activity Linked to Future Lesion Risk

Multi-Analyte Blood Test May Help Distinguish MS Relapse from Pseudoexacerbation

Ublituximab Linked to Lower Relapse and MRI Activity in Treatment-Naïve Relapsing MS

Serum GFAP May Help Predict Progression Risk in Multiple Sclerosis

High-Efficacy Therapies Linked to Lower Disease Activity in Real-World MS Cohort

Machine Learning Model Identifies Biologically Distinct MS Subtypes Using MRI and sNfL Levels

GFAP Levels Correlated With Clinical and MRI Outcomes in Individuals with Relapsing Multiple Sclerosis

8-Year Data Demonstrate Sustained Safety and Efficacy of Enspryng Tretment for Individuals with NMOSD

Long-Term Data Support Treatment with Briumvi Over Aubagio for Individuals with RMS

Ocrelizumab Linked to Improved Cognitive Outcomes in Individuals with Relapsing Multiple Sclerosis Compared with Interferon Beta.

MRI-Guided Treatment Escalation May Reduce Relapse Risk in Stable MS Patients

Head-and-Neck Cooling Enhances Exercise Tolerance in Individuals with MS

People Living with HIV Demonstrate a Lower Risk of Multiple Sclerosis

Anti-CD20 Therapy for MS Linked to Secondary Hypogammaglobulinemia